A Rutgers spin-off company, PONS, developed by an engineer who lost family to illness, improves early disease detection.

"This partnership with Siemens Healthineers marks a pivotal step in expanding access to advanced neuroimaging on a global scale," said Kyle Frye, CEO of Cortechs.ai. "By combining our innovative AI ...

By measuring the magnetic fields of the brain, researchers found that different contemplative practices uniquely change how ...

Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and ...

Amsterdam, the Netherlands Thursday, March 5, 2026, 13:00 Hrs [IST] ...

Unlike most frontier neuroscience projects that rely primarily on state funding, this one has been built through a rare mix ...

Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

New AI-Driven Planning Platform Designed to Unlock a New Class of Disease-Modifying Therapies for CNS Disorders MUNICH & REDWOOD CITY, Calif.--(BUSIN ...

With AiMIFY ® set to reinforce Bracco's core MRI portfolio in clinical practice and the Avicenna.AI collaboration extending ...

Buying Gleamer will expand the capabilities RadNet acquired through the DeepHealth buyout in 2020, particularly in X-ray, and ...

A University of Michigan AI model diagnoses more than 50 brain disorders from MRI scans in seconds, with up to 97.5 percent ...